Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B | Circulation Research
What is HLA Typing And Why You Should Have Your Cells Genotyped?
HLA typing in cancer
Development of immunocompatible pluripotent stem cells via CRISPR-based human leukocyte antigen engineering | Experimental & Molecular Medicine
Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy | Molecular Medicine | Full Text
HLA-DR - Wikipedia
Differential expression of several surface markers on HLA-DR+ and... | Download Scientific Diagram
HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis - ScienceDirect
Gift of Life
Frontiers | Regulation of NK-Cell Function by HLA Class II
HLA Gene May Predict if Cancer Immunotherapy Will Work - NCI
RETRACTED ARTICLE: Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs | Nature
Presence of HLA‐DR Molecules and HLA‐DRB1 mRNA in Circulating CD4+ T Cells - Revenfeld - 2016 - Scandinavian Journal of Immunology - Wiley Online Library
Expression of the T cell activation markers HLA-DR and CD38 on... | Download Scientific Diagram
HLA-DR Antibodies - Beckman Coulter Life Sciences
Why HLA?
Bone Marrow Donor Programme (Singapore) - HLA matching is used to match patients and donors for bone marrow transplants. There are many HLA markers, and each marker has a name. The names
HLA-typed cells and their role in immunotherapy - PromoCell
Human leukocyte antigen class II quantification by targeted mass spectrometry in dendritic-like cell lines and monocyte-derived dendritic cells | Scientific Reports
HLA-A & HLA-B Gene Spotlight - Genomind
HLA Services – Family Cord
Introduction to Flow Cytometric Analysis | Flow Cytometry
Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor: Molecular Therapy
Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity | eLife
SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells - ScienceDirect
Frontiers | HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation
HLA typed cancer cells
